<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://10.9.150.37:8080/dspace//handle/atmiyauni/1433" />
  <subtitle />
  <id>http://10.9.150.37:8080/dspace//handle/atmiyauni/1433</id>
  <updated>2026-04-27T18:57:52Z</updated>
  <dc:date>2026-04-27T18:57:52Z</dc:date>
  <entry>
    <title>Formulation and Evaluation of Clindamycin Phosphate Microsponge Gel for Topical Drug Delivery</title>
    <link rel="alternate" href="http://10.9.150.37:8080/dspace//handle/atmiyauni/2286" />
    <author>
      <name>Kadivar, Richa</name>
    </author>
    <author>
      <name>Joshi, Rachana</name>
    </author>
    <id>http://10.9.150.37:8080/dspace//handle/atmiyauni/2286</id>
    <updated>2025-01-10T11:09:19Z</updated>
    <published>2024-11-01T00:00:00Z</published>
    <summary type="text">Title: Formulation and Evaluation of Clindamycin Phosphate Microsponge Gel for Topical Drug Delivery
Authors: Kadivar, Richa; Joshi, Rachana
Abstract: Clindamycin is a potent lincosamide antibiotic against susceptible anaerobic&#xD;
bacteria and gram-positive aerobes. Furthermore, CLN also has anti-inflammatory&#xD;
activities. It is applied topically in the management of acne vulgaris.The current&#xD;
research was focused on gel loaded for the topical delivery to Clindamycin&#xD;
phosphate to overcome short half life problem of the drug and to minimize the side&#xD;
effects of drug with conventional gel. The FTIR study revealed that there was no&#xD;
interaction between drug and polymer and the combination is suitable for&#xD;
preparation of microsponges. Clindamycin phosphate loaded microsponges were&#xD;
prepared by oil in oil emulsion solvent diffusion method as the drug is highly water&#xD;
soluble and belongs to BCS class III. The microsponges were prepared by using&#xD;
ethyl cellulose as the polymer and incorporated into carbopol gel. The&#xD;
microsponges were evaluated for visual inspection, % yield, % drug content, %&#xD;
entrapement efficiency and particle size. The effect of formulation variables like&#xD;
stirring speed and drug:polymer ratio were evaluated on microsponges. The&#xD;
optimized formulation with drug:polymer ratio of 1:1, stirring speed of 1000rpm&#xD;
had the drug content of 78.69% and percent entrapement efficiency was found to&#xD;
be 87.94% The results concluded that as the drug:polymer ratio increases, drug&#xD;
content and entrapement efficiency decreases. The particle size of optimized batch&#xD;
of microsponges was found to be 37.44μm. The results of particle size analysis&#xD;
concluded that as the drug:polymer ratio increases, particle size increases. The&#xD;
microsponges of batch CLPA1-CLPA9 were subjected to in-vito drug release&#xD;
study by Franz diffusion cell apparatus. The batch showed the controlled release of&#xD;
95.49% of drug release at 10 hrs. The results of in-vitro drug release showed that&#xD;
as the drug:polymer ratio increases, more controlled release formulation is&#xD;
obtained. The microsponges were incorporated into carbopol gel was evaluated for visual inspection, pH, spreadability and stability of gel at room temperature for 1&#xD;
month. The transparent white microsponge gel had the pH of 6.38 with&#xD;
spreadability of 7.05 g cm/s. The gel was found to be stable after 1 month. In-vitro&#xD;
antibacterial activity was observed for microsponge gel and compared with&#xD;
marketed 1%w/w CLP gel (Clindac A).</summary>
    <dc:date>2024-11-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Solubility Enhancement Of Poorly Soluble Drugs By Formulation Of Solid Dispersion Using Soluplus® As A Carrier</title>
    <link rel="alternate" href="http://10.9.150.37:8080/dspace//handle/atmiyauni/1434" />
    <author>
      <name>Sheikh, Mohammed Farhan M.</name>
    </author>
    <author>
      <name>Ughreja, Reena</name>
    </author>
    <id>http://10.9.150.37:8080/dspace//handle/atmiyauni/1434</id>
    <updated>2024-09-27T06:03:45Z</updated>
    <published>2024-07-16T00:00:00Z</published>
    <summary type="text">Title: Solubility Enhancement Of Poorly Soluble Drugs By Formulation Of Solid Dispersion Using Soluplus® As A Carrier
Authors: Sheikh, Mohammed Farhan M.; Ughreja, Reena
Abstract: Treatment of tuberculosis makes great use of rifampicin. While Abiraterone Acetate is generally&#xD;
used for the treatment of prostate cancer, Duloxetine Hydrochloride is advised for the treatment of&#xD;
major depressive disorder. Still, the low water solubility of all these drugs affects their&#xD;
bioavailability. Thus, this work sought to generate solid dispersions thereby enhancing the&#xD;
solubility and hence the dissolution rate of Rifampicin, Duloxetine hydrochloride, and Abiraterone&#xD;
Acetate. Soluplus® was used as a carrier to enhance solubility; phase solubility investigations&#xD;
carried out in preliminary trials helped to ascertain the ratio. First investigations were carried out&#xD;
to select the suitable solvent and techniques; thereafter, solid dispersions were developed. The&#xD;
Physical characterization was done by DSC and FT-IR. DSC was performed to determine the&#xD;
thermal characteristics of the drug and FT-IR was performed to determine the compatibility&#xD;
between the drug and polymer. Melt and solvent evaporation techniques were used to produce the&#xD;
solid dispersion. The batches had ratios ranging from 1:1, 1:2, and 1:3. %Drug content, %yield,&#xD;
solubility studies, and in-vitro dissolution studies were among the evaluation parameters&#xD;
performed for the solid dispersion assessment. The batch showing good results was selected for&#xD;
further investigation with XRD, DSC, and FT-IR methods. The best batches of all the drugs&#xD;
(Rifampicin, Duloxetine HCL and Abiraterone Acetate) showed enhancement in the solubility and&#xD;
dissolution rate.</summary>
    <dc:date>2024-07-16T00:00:00Z</dc:date>
  </entry>
</feed>

